All In MedTech

Device Trial Radar · NCT05485922

Performance of a Single-use Intermittent Micro-hole Zone Catheter

A Randomized, Open-labelled, Crossover Study Confirming Performance of a Single-use Intermittent Micro-hole Zone Catheter in a Population of Adult Male Intermittent Catheter Users

Last checked: Nov 20, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

42

Actual

Start

Sep 23, 2022

Primary completion

Nov 4, 2022

Study completion Nov 4, 2022

Sponsor

Lead sponsor
Coloplast A/SNot on our public-company list
Sponsor type
Industry
First posted
Aug 3, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomized, controlled crossover study was to assess the performance of a new micro-hole zone catheter compared to a conventional 2-eyelet catheter in 42 male intermittent catheter users. The main objective of this study was to demonstrate superiority of the micro-hole zone catheter in terms of number of flow-stop episodes and residual volume at first flow-stop, with the catheterization performed by a health care professional in a hospital setting compared to a conventional two-eyelet catheter.

Conditions

  • Urinary Incontinence
  • Retention, Urinary

Interventions

  • Investigational device - intermittent catheter with a micro-hole zoneDevice

    The investigational device was a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.

  • Comparator device -VaPro intermittent catheterDevice

    The comparator device is a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Flow-stop EpisodesTime frame: Immediately after the procedure/catheterization
  2. Residual Urine at 1st Flow-stopTime frame: When the first flow-stop appeared, the amount of voided urine was measured.
  3. Number of Flow-stop EpisodesTime frame: Immediately after catheterisation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sanos Clinic

    Gandrup, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.